PRA Health Sciences, Inc.
CIK 0001613859
Revenue (TTM)
$3.24B
+9.7% YoY
Q1 Apr 2021
Net Income (TTM)
$202.73M
+163.4% YoY
Q1 Apr 2021
EPS Diluted (TTM)
$3.12
−44.7% YoY
Q1 Apr 2021
Gross Margin
20.5%
Q1 Apr 2021
Operating Margin
9.3%
Q1 Apr 2021
Net Margin
6.2%
Q1 Apr 2021
Free Cash Flow (TTM)
$254.53M
Q1 Apr 2021
Cash
$690.26M
Q1 Apr 2021
Total Debt
$1.18B
Q1 Apr 2021
Shares Outstanding
64.8M sh
Q1 Apr 2021